Is isolated congenital heart block associated to neonatal lupus requiring pacemaker a distinct cardiac syndrome?

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 5, 2004, Pages 615-620

  Cruz, Rosana B P ^a   Viana, Vilma S T ^a   Nishioka, Silvana A D ^a   Martinelli F, Martino ^a   Bonfa, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Congenital heart block; Neonatal lupus syndrome; Pacemaker; Systemic lupus erythematosus

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CHILD; CLINICAL ARTICLE; CONGENITAL HEART BLOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART ELECTROPHYSIOLOGY; HOLTER MONITORING; HUMAN; INFANT; MALE; MITRAL VALVE REGURGITATION; NEONATAL LUPUS SYNDROME; NEWBORN; NEWBORN DISEASE; STATISTICAL SIGNIFICANCE; SYMPTOM; SYNCOPE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREADMILL EXERCISE;

EID: 2442507527     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00495.x     Document Type: Article

References (40)

1. Michaelsson M, Engle MA. Congenital complete heart block: An international study of the natural history. Cardiovasc Clin 1972; 4:85-101.
2. Yater WM. Congenital heart block - Review of the literature, report of a case with incomplete hetrotaxy; the electrocardiogram in dextrocardia. Am J Dis Child 1929; 38:112-135.
3. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995; 92:442-449.
4. Buyon JP, Winchester R. Congenital complete heart block: A human model of passively acquired autoimmune injury. Arthritis Rheum 1990; 33:609-614.
5. Pordon CM, Moodie DS. Adults with congenital complete heart block: 25-year follow-up. Cleve Clin J Med 1992; 59:587-590.
6. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital heart block diagnosed in utero. Heart 1996; 75:190-194.
7. Moak JP, Baron KS, Hougen TJ, et al. Congenital heart block: Development of late-onset cardiomyopathy, a previously under appreciated sequela. J Am Coll Cardiol 2001; 37:238-242.
8. Hubscher O, Batista N, Rivero S, et al. Clinical and serological identification of 2 forms of complete heart block in children. J Rheumatol 1995; 22:1352-1355.
9. Lev M. Pathogenesis of congenital atrioventricular block. Prog Cardiovasc Dis 1972; 25:145-157.
10. Askanase AD, Friedman DM, Copel J, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002; 11:143-151.
11. Brucato A, Jonzon A, Friedman D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus 2003; 12:427-453.
12. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106:2145-2161.
13. Scanavacca MI, Brito FS, Maia I, et al. Diretriz sobre arritmias cardiacas. Arq Bras Cardiol 2002; 79:1-50.
14. Kurata N, Tan EM. Identification of antibody to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19:574-580.
15. Elkon KB, Culhane L. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with sicca syndrome and lupus erythematosus. J Immunol 1984; 132:2350-2356.
16. nd edition, Washington, American Society of Microbiology, 1980, pp. 866-870.
17. Gharavi AE, Harris EN, Asherson RA, et al. Anticardiolipin antibodies: Isotope distribution and phospholipid specificity. Am Rheum Dis 1987; 46:1-6.
18. Viana VST, Garcia S, Nascimento JHM, et al. Induction of in vitro heart block is not restricted to affinity purified anti-52kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 1998; 7:141-147.
19. Vitali C, Bombardieri S, Moutsopoulos HM, et al. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann Rheum Dis 1996; 55:116-121.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
21. Kasukawa R, Sharp GC. Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam, Elsevier: 1987, pp. 23-47.
22. Reed BR, Lee LA, Harmon C, et al. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr 1983; 103:889-891.
23. Praprotnick S, Bozic B, Kveder T, et al. Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: A prospective study. Clin Exp Rheumatol 1999; 17:63-68.
24. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: Outcome in mothers and children. Ann Intern Med 1994; 120:544-551.
25. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001; 44:647-652.
26. Julkunen H, Kurki P, Kaaja R, et al. Isolated Congenital Heart Block: Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993; 36:1588-1598.
27. Boutjdir M, Chen L, Zhang ZH, et al. Arrhythmogenicity of IgG and 52- SSA/Ro affinity purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80:354-362.
28. Silverman ED, Mamula M, Hardim JA, et al. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol 1991; 18:120-124.
29. Tran HB, Ohlsson M, Beroukas D, et al. Subcellular redistribution of La/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system. A clue to the pathogenesis of congenital heart block. Arthritis Rheum 2002; 46:202-208.
30. Buyon JP, Hiebert R, Joshua BS, et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31:1658-1666.
31. Grimaldi CM, Michael DJ, Diamon B. Cutting edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001; 167:1886-1890.
32. Esscher E, Scott JS. Congenital heart block and maternal systemic lupus erythematosus. Br Med J 1979; 1:1235-1238.
33. Fox RJ Jr, McCuistion CH, Schoch EP Jr. Systemic lupus erythematosus: Association with previous neonatal lupus. Arch Dermatol 1979; 115:340.
34. Lanham JG, Walport MJ, Hughes GRV. Congenital heart block and familial connective tissue disease. J Rheumatol 1983; 10:823-825.
35. McCue CM, Mantakas ME, Tinglestad JB, et al. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56:82-90.
36. Lee LA, Coulter S, Erner S, et al. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro antibody. Am J Med 1987; 83:793-796.
37. Boutjdir M, Chen L, Zhang ZH, et al. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 1998; 44:11-19.
38. Buyon JP, Tseng CE, Di Donato F, et al. Cardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-KDa SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum 1997; 40:655-660.
39. Nakamura K, Robertson M, Liu G, et al. Complete heart block and sudden death in mice over expressing calreticulin. J Clin Invest 2001; 107:1245-1253.
40. Miranda-Carús ME, Askanase AD, Clancy RM, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-a by macrophages. J Immunol 2000; 165:5345-5351.